[1]
Sperlich, C. and Saad, F. 2013. Optimal management of patients receiving cabazitaxel-based chemotherapy. Canadian Urological Association Journal. 7, 1-2-S1 (Feb. 2013), S18-S24. DOI:https://doi.org/10.5489/cuaj.275.